CXCL13 binds the CXCR5 receptor and regulates homing of B cells and, recently it has been suggested as a prognostic marker for multiple sclerosis (MS), another chronic inflammatory autoimmune disease. Here, CXCL13 is linked to myeloid sarcoma.